Search results
- (-) Remove Press releases filter Press releases
Oxford BioMedica plc Management and Board change
--Appointment of new Chief Financial Officer and Company Secretary --
Oxford BioMedica Announces Interim Update on ProSavin® Phase I/II Study in Parkinson's Disease
-- Positive review of all patient cohorts by Data Monitoring Committee --
Oxford BioMedica Announces Research and Development Collaboration for Glaucoma
-- Research and development agreement signed with Mayo Clinic --
Oxford BioMedica Announces 5T4 Antibody Research Collaboration with ImaginAb
-- ‘In vivo’ diagnostic rights granted for cancer imaging --
Oxford BioMedica Plc Management and Board Changes
--Oxford BioMedica Appoints Alex Lewis as Director of Corporate Activities and Strategy--